TARRYTOWN, N.Y. , Aug.
22, 2024 /PRNewswire/ -- Aerolase Corp. was just named again to the annual Inc. 5000 list of America's fastest-growing private companies in revenues.
In the 2024 list, it is #23 in healthcare products, up from #139 when the company debuted in Inc., and #1516 among the 5000, up from #2020 in its debut. The ranking rise comes despite growing off of a much larger revenue base.
After the very strong growth in 2023, Aerolase is tracking similarly in 2024. "It is gratifying to see that our lasers' unique efficacies, versatility, and high performance with safety on all skin tones are resonating with consumers and practitioners alike," said Pavel Efremkin, CEO of Aerolase. This year, an independent consulting firm's Voice of Customer survey found that Aerolase achieved a Net Promoter Score (NPS) of 85, an extraordinarily high metric in any industry.
Major drivers of Aerolase's recent growth include excellence in acne treatment, unique versatility of efficacious treatment range, and uncommonly high ROI to users in the main industry segments: dermatologists, plastic surgeons, and the most rapidly growing segment, medspas. Another key contributor is Aerolase lasers' unique safety and efficacy to be combined in the same treatment session with aesthetic injectables – toxins, fillers, and others. This enables aesthetic clinics to offer proprietary, differentiated services and optimize practice throughput.
A recent peer-reviewed study underlines Aerolase excellence .